Debashree Guha

HYPORT Adjuvant Acute toxicity and patient dosimetry quality assurance results- Interim Analysis.

R. Ahmed, S. Chatterjee, S. Chakraborty, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial

R. Ahmed, S. Chatterjee, S. Chakraborty, 2020, Trials.

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial

R. Ahmed, S. Chatterjee, S. Chakraborty, 2020, Trials.